Digest Network Come funziona
Network
/
Società
Si
Non verificato

Sinovac Biotech Ltd.

Di cosa scriviamo

BiotecnologiaFarmaceuticaHIV, AIDS e malattie autoimmuniMedicina - VarieSalute

17 comunicati stampa

Guarda tutti i comunicati
22/01/2026
Biotecnologia
Farmaceutica
Salute
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
04/01/2026
Mercato del lavoro
Legge/Diritto
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
04/01/2026
HIV, AIDS e malattie autoimmuni
Biotecnologia
Farmaceutica
Salute
Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
17/12/2025
Biotecnologia
Farmaceutica
Salute
Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder Meeting
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
10/07/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Mercato del lavoro
Newly Elected Directors of Sinovac Hold the First Board Meeting
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
18/06/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
Mercato del lavoro
SINOVAC Announces New Board Member
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
16/06/2025
Salute
HIV, AIDS e malattie autoimmuni
Industria
Farmaceutica
Biotecnologia
SINOVAC Board of Directors Alerts Shareholders to Advantech/Prime Success’ New Lawsuit, Which Threatens to Prevent Payment of US$55.00 Special Dividend to All Valid Shareholders
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
12/06/2025
Biotecnologia
Farmaceutica
Industria
Sanità
Salute
HIV, AIDS e malattie autoimmuni
Mercato azionario
Titoli e azioni
SINOVAC’s Board of Directors Issues a Letter to Shareholders Outlining Clear Pathway to Restore Fairness and Deliver Value to All Shareholders
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
23/05/2025
Biotecnologia
HIV, AIDS e malattie autoimmuni
Salute
Farmaceutica
Medicina - Varie
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2024 Annual Report
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0
30/04/2025
Titoli e azioni
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Farmaceutica
Biotecnologia
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend
Fonte
Sinovac Biotech Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0